SSRI-induced insomnia may be related to stimulation of the 5-HT2 receptors in the brain sleep centers, part of the serotonergic pathway that projects to the cholinergic neurons of the lateral tegmentum, which are critical for inhibition and sleep maintenance [96,97]. The gene discussed is HTR2A; the disease is insomnia measurement.